Phagenesis
Developms a device to treat dysphagia;a condition that disables the safe swallowing of food
Total raised
€64M
€63,765,361
Funding rounds
4
Investors
5
distinct backers
Active since
2010-08
latest 2024-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood43
base rate 53% for Series D+
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood22
base rate 12% (2+ rounds)
- ▲ 4 rounds raised
- ▲ €30M+ raised
- ▲ 19y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
4 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-03-04 | Series D+ | €39M | Aphelion,British Patient Capital,EQT Life Sciences,Northern Gritstone,Sectoral | View deal → |
| 2013-05-01 | Series B | €15M | — | View deal → |
| 2011-10-01 | Other | €7.0M | — | View deal → |
| 2010-09-01 | Other | €2.8M | — | View deal → |